The FDA has accepted the NDA for zoliflodacin for the treatment of uncomplicated gonorrhea in adults and pediatric patients 12 years and older.

Explore how evolving tools and emerging pathogens are reshaping the diagnosis and treatment of Pelvic Inflammatory Disease.

The Department of Health (DoH) has approved the roll-out of the world’s first vaccination programme to target gonorrhoea in ...

The rise in antibiotic-resistant "super-gonorrhoea" is "particularly concerning", according to the UK Health and Security ...

46TH AVENUE. NO ONE ELSE WAS HURT. THE LAKE COUNTY MAN GOT SICK FROM A RARE AND DEADLY BACTERIA AFTER BEING HURT AT LAKE DORA IN TAVARES. WESH TWO DAVID JONES CAUGHT UP WITH THAT MAN AND SPOKE ...

Adolescents who live in Kisumu’s informal settlements and are sexually active are likely to have chlamydia or gonorrhea, or ...

A vaccine targeting gonorrhea will soon be rolled out on the NHS. This will make England and Wales the first two countries in ...

Research has shown that the 4CMenB vaccine provides some protection against an infection from the Neisseria gonorrhoeae bacteria. On average, the vaccine is effective in preventing gonorrhoea ...

This grant will support the continued clinical development of Debio 1453, a first-in-class antibiotic with a novel mechanism of action to treat Neisseria gonorrhoeae infections. The initial grant ...